Stocks-INCY-Incyte Corp.

INCY Incyte Corp.

57.66 0 (0%)
市場休市延遲價格來源為納斯達克, 美元
交易

Incyte Corp. 價格

-1.91% 過去1周
Created with Highcharts 4.2.7 /Highstock 4.2.7
市值
12.92B
日範圍
56.91
-
57.85
52周範圍
50.18
-
80.08
交易量(3個月)
1.83M
市盈率
30.64
收入
3.61B
熱門討論
Edward Anthony Martin White
$INCY (Incyte Corp.) is a biopharmaceutical company 🧬 that focuses on the discovery, development, and commercialization of innovative medicines, particularly in the field of oncology and inflammation. With a robust pipeline, a history of successful drug development, and a commitment to cutting-edge... 顯示更多 翻譯
DeepNews
$INCY (Incyte Corp.) Incyte (INCY) Banks on Opzelura as Jakafi Faces Competition Incyte’s Jakafi, a first-in-class JAK1/JAK2 inhibitor, is also approved for myelofibrosis. The approval of another JAK1/JAK2 inhibitor for the same indication will pose competition for Jakafi, particularly given Ojjaara’s... 顯示更多 翻譯
GiovanniMioni
📈 In una giornata altalenante dei mercati, alcuni titoli spiccano positivamente. Ecco i Migliori titoli di oggi nel S&P500! 🚀 📊 Dati del giorno: $INCY (Incyte Corp.) 🧬 Ultimo Prezzo: $62,04 Variazione: +$5,00 Variazione Percentuale: +8,77% $ALK (Alaska Air Group Inc) ✈️ Ultimo Prezzo: $37,36 Variazione:... 顯示更多 翻譯
MarketUpdates
已修改
$INCY (Incyte Corp.) 預計公布 2023 年第 4 季財報
13
二月
報告
預計 Q4, 2023 的財報
通知我
INCY
INCY
Incyte Corp.
57.66
0
(0%)
交易
MarketUpdates
已修改
$INCY (Incyte Corp.) Q4 2023 earnings report is expected to be released 翻譯
undefined logo
INCY
Incyte Corp.
57.54
0 (0.00%)
交易

分析師預測

共識
適度買入
價格目標
69.86

ESG:洞察力新來源

通過ESG(環境、社會和治理)評分,獲得公司的可持續發展計劃。
0
100
54
產業 
平均值 45 
41
環境
43
社會
70
企業治理

人們還購買